Federal Register / Vol. 60, No. 8 / Thursday, January 12, 1995 / Notices 2971

*The phrase ‘‘population laboratory’’ as used

herein refers to an organization dedicated to

epidemiologic, sociologic, and economic study of

public health interventions in a well defined urban

population. Projects may or may not include

support from a laboratory as defined in the

traditional clinical setting.

SUPPLEMENTARY INFORMATION:

I. Purpose

Section 921 of the Public Health

Service Act (42 U.S.C. 299c) establishes

the National Advisory Council for

Health Care Policy, Research, and

Evaluation. The Council provides

advice to the Secretary and the

Administrator, Agency for Health Care

Policy and Research (AHCPR), on

matters related to the activity of AHCPR

to enhance the quality, appropriateness,

and effectiveness of health care services

and access to such services through

scientific research and the promotion of

improvements in clinical practice and

the organization, financing, and delivery

of health care services.

The Council is composed of public

members appointed by the Secretary.

These current members are: Marion F.

Bishop, Ph.D.; Linda Burnes Bolton,

Dr.P.H.; John W. Danaher, M.D.;

William S. Kiser, M.D.; Walter J.

McNerney, M.H.A.; and Louis F.

Rossiter, Ph.D.

Eleven new members will be

appointed shortly.

There also are Federal ex officio

members. These members are:

Administrator, Substance Abuse and

Mental Health Services Administration;

Director, National Institutes of Health;

Director, Centers for Disease Control

and Prevention; Administrator, Health

Care Financing Administration;

Commissioner, Food and Drug

Administration; Assistant Secretary of

Defense (Health Affairs); and Chief

Medical Director, Department of

Veterans Affairs.

II. Agenda

On Monday, January 23, 1995, the

open portion of the meeting will begin

at 1:00 p.m. with the call to order by the

Council Chairman. The Administrator

will introduce new and reappointed

members to the Council and discuss the

broad strategic plan for AHCPR and

related organizational issues. The

Administrator, AHCPR, will conclude

the afternoon meeting with a discussion

of new AHCPR initiatives. The meeting

will adjourn at 5:45 p.m.

On Tuesday, January 24, 1995, the

open portion of the Council meeting

will resume at 8:30 a.m. with

administrative announcements, a

discussion of legislative and budget

authorities, and a discussion of tools for

accomplishing the AHCPR mission. The

open meeting will adjourn at 10:30 a.m.

The Council will begin the closed

portion of the meeting to discuss the

AHCPR grant portfolio from 10:30 a.m.

to 12:00 p.m. The meeting will then

adjourn at 12:00 p.m.

Agenda items are subject to change as

priorities dictate.

Dated: January 6, 1995.

Linda K. Demlo,

Acting Administrator.

[FR Doc. 95–708 Filed 1–11–95; 8:45 am]

BILLING CODE 4160–90–P

Centers for Disease Control and

Prevention

[Announcement Number 515]

Cooperative Agreement Program for

Urban Center(s) for Applied Research

in Public Health

Introduction

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1995

funds for a cooperative agreement

program for the establishment of an

Urban Center(s) for Applied Research in

Public Health. Activities coordinated by

the Urban Center(s) are intended to use

‘‘population laboratories’’* to produce

information useful in health policy

decisions and planning, thereby

enhancing the effectiveness, quality,

and cost-effectiveness of preventive and

health care delivery systems and

improving the health of persons living

in the city.

The Public Health Service (PHS) is

committed to achieving the health

promotion and disease prevention

objectives of ‘‘Healthy People 2000,’’ a

PHS-led national activity to reduce

morbidity and mortality and improve

the quality of life. As the lead Federal

agency for prevention, CDC has

emphasized evaluation of prevention

programs. As part of that continuing

effort, CDC is strengthening efforts to

assure that public health priorities and

program strategies maximize the health

of the population relative to the

resources expended. Epidemiologic

research is required in urban areas both

to recognize emerging problems of

illness and injury, to describe trends in

risk factors, especially among youth and

diverse populations, and to better

characterize known public health

problems. While research is required to

identify persons at highest risk, studies

are particularly needed to evaluate the

efficacy, effectiveness, and economic

feasibility of proposed and ongoing

preventive interventions.

Residents of many urban

neighborhoods have high rates of

disease and injury, such as sexually

transmitted diseases and AIDS,

tuberculosis, lead toxicity, diabetes,

asthma, violence, and teen pregnancy.

Interventions to reduce these problems

must address the complex social,

behavioral, and economic conditions of

the communities as well as the

determinants of the specific diseases

and injuries themselves. These

comprehensive, multidisciplinary

interventions need to be implemented

and evaluated to determine their

effectiveness and cost effectiveness.

This cooperative agreement is intended

to create an interdisciplinary urban

center to work with the community. The

center will assess the health impact of

interventions targeted to address

underlying problems contributing to

high rates of disease and injury.

CDC also recognizes the vital

importance of measuring the impact on

health (including effectiveness, safety,

and cost) of prevention policies,

programs, and practices. The assessment

of prevention effectiveness is the

ongoing process of applying evaluation

tools to prevention practices.

This announcement is related to all of

the priority area(s) of Healthy People

2000. (For ordering a copy of ‘‘Healthy

People 2000,’’ see the section ‘‘Where to

Obtain Additional Information.’’)

Authority

This program is authorized under

section 301 of the Public Health Service

Act (42 U.S.C. 241) as amended.

Smoke-Free Workplace

The Public Health Service strongly

encourages all grant recipients to

provide a smoke-free workplace and

promote the non-use of all tobacco

products. This is consistent with the

PHS mission to protect and advance the

physical and mental health of the

American people.

Eligible Applicants

Assistance will be provided only to

local (city/county) health departments

or research organizations collaborating

with local health departments of the

fifty largest U.S. cities ranked by

population per square mile (as

determined from the County and City

Book 1994—refer to Attachment A).

Applications should be made by the

local (city or county) department of

health or by one or more other

organizations (e.g., academic, technical,

or community organizations) with a

written indication of support from the

local health department. Therefore,

there should be only one application per
2972 Federal Register / Vol. 60, No. 8 / Thursday, January 12, 1995 / Notices

geographic area (e.g., the responsible

local health agency may apply as a

single applicant or in consortium). The

list of organizational partners should

include at least one with demonstrated

substantial expertise in epidemiologic

research, evaluation, economics, and

quantitative policy analysis. In addition,

collaboration with health care

providers, especially managed care

organizations, will be of significant

importance. The interests of the

community organizations should be

incorporated into the development of

this cooperative agreement.

Availability of Funds

Federal financial assistance totalling

approximately $600,000 is available in

FY 1995 to fund up to three awards in

support of core activities. Awardees will

be expected to secure additional

funding from other sources (public and

private sector support). It is expected

that the award(s) will be made on or

about April 1, 1995, and will extend for

a 12-month budget period. Projects may

be approved for a period of up to 5

years, renewable on an annual basis.

Federal funding estimates may vary and

are subject to change. Continuation

awards within an approved project

period will be made on the basis of

satisfactory progress and availability of

funds. Funds for specific program

project activities may be added to the

awards in subsequent years upon

availability.

Grant awards cannot supplant

existing funding for epidemiologic

research in urban areas. Eligible

applicants are encouraged to secure

additional funds from other sources,

including consortia agreements, as

necessary, to meet the requirements of

the program and strengthen the overall

application.

Purpose

The purpose of this cooperative

agreement is to assist the recipient in

the development of an urban

‘‘population laboratory’’ which utilizes

the combined resources of the recipient,

other local organizations, the local

community, and CDC. The goal is to

promote collaborative epidemiologic

and prevention effectiveness research

on the most serious health threats facing

urban residents; and thereby,

developing information for public

health planning and for improving the

health of citizens. A key aim of this

center will be to identify opportunities

related to the inner city. The Center will

be beneficial to CDC by unifying the

process of community planning.

The specific objectives of the

population laboratory are as follows:

A. To assess the availability and

capacity of existing prevention

programs offered by State and local

health agencies; public and private

health care providers; and other

community or lay organizations.

B. To foster the development of

collaborative relationships among the

population laboratory, CDC, and the

State and local health departments for

the purpose of focusing the expertise of

academic institutions and community

based organizations on high priority

urban health problems.

C. To develop and implement

organizational and sociological

intervention studies to optimize

effectiveness in prevention programs by

involving the community in planning,

program design, and related public

health activities.

D. To develop a multidisciplinary

approach to prevention programs and to

develop, test, evaluate, and disseminate

model programs to enhance health

promotion and disease and injury

prevention in various settings and

populations.

Program Requirements

Applications that do not meet the

following requirements will be

considered non-responsive. Applicants

must:

• Provide evidence of working

relationships with partner organizations

and community leaders which allow

evaluation and implementation of any

proposed intervention activities.

• Provide evidence of supplemental

technical and financial assistance from

other ‘‘partner organizations.’’

• Provide evidence of expertise in

research related to urban and minority

health issues or a planned process for

developing such expertise in a short

timeframe.

• Provide evidence/plans for core

activities, demonstration projects,

collaborations/collaborative projects

with State/local health departments and

academic institutions.

In conducting activities to achieve the

purpose of this program, the recipient

will be responsible for the activities

under A, (Recipient Activities), and

CDC will be responsible for the

activities listed under B, (CDC

Activities).

A. Recipient Activities

1. Establish and operate a

demonstration population laboratory for

epidemiologic, social science,

behavioral science, and prevention

effectiveness research.

a. Establish the population laboratory

in a defined population in a

geographically defined urban area.

b. Establish an Executive Board

composed of representatives from the

community as well as public health,

academic, health care community

leaders and private partners to provide

advice and guidance to the Urban

Center Project Director, as needed. The

recipient will obtain participation and

input from community-based

organizations in the proposed

geographic area.

2. Propose and conduct

multidisciplinary research dedicated to

improving the health and well-being of

urban populations. Address research

topics of typical urban health problems

(e.g., HIV transmission and AIDS,

tuberculosis, violence, lead poisoning,

immunization, diabetes, and

cardiovascular disease).

3. Manage, analyze, and interpret data

from population laboratory projects, and

publish and disseminate important

public health information stemming

from population laboratory projects.

4. Monitor and evaluate scientific and

operational accomplishments of the

population laboratory and progress in

achieving the purpose and overall goals

of this program.

5. Document findings in the scientific

literature.

6. Evaluate specific interventions

(programs) to address typical urban

health problems researched in #2 of

Recipient activities.

7. Foster the development of

prevention programs that are not

categorical but that cut across health

issues that affect common populations.

Coordinate activities with CDC’s

Prevention Centers program.

B. CDC Activities

1. Assign a CDC scientist on-site to

function as liaison, provide technical

assistance, and facilitate collaboration of

population laboratory staff with CDC

staff. The assignee will provide crosscutting coordination for all CDC

Centers, Institute, and Offices (CIO)

programmatic activities which are

relevant to the Urban Center(s)’

activities, especially activities

undertaken by CDC’s Prevention Centers

program.

2. Provide consultation and scientific

and technical assistance in designing

and conducting individual population

laboratory projects.

3. Participate in analysis and

interpretation of data from population

laboratory projects. Participate in the

dissemination of findings and

information stemming from population

laboratory projects.

4. Monitor and evaluate scientific and

operational accomplishments of the

population laboratory and progress in
Federal Register / Vol. 60, No. 8 / Thursday, January 12, 1995 / Notices 2973

achieving the purpose and overall goals

of this program.

Evaluation Criteria

Upon receipt, applications will be

reviewed by CDC staff for completeness

and responsiveness as outlined under

the previous heading Program

Requirements (a listing of where these

requirements are described and/or

documented in the application will

facilitate the review process).

Incomplete applications and

applications that are not responsive will

be returned to the applicant without

further consideration.

Applications which are complete and

responsive will undergo an initial peer

evaluation of the scientific and

technical merit to warrant further

review; the CDC will withdraw from

further consideration applications

judged to be noncompetitive and

promptly notify the principal

investigator/program director and the

official signing for the applicant

organization. The second review will be

conducted by senior Federal staff, who

will consider the results of the first

review together with program need and

relevance. Awards will be made based

on merit and priority score ranking by

the peer review, program review by

senior Federal staff, and the availability

of funds.

A. The Objective Review Committee

may recommend approval or

disapproval based on the content of the

application and the following criteria:

1. The Population Laboratory for

Applied Research in Public Health

Purpose (5 points)

The extent to which the efforts will

result in innovative approaches or

interventions to meet health priorities,

emerging health and other health needs

of urban residents, or an identified

demographic group, or combination

thereof.

2. Overall program plan (10 points)

The extent to which the overall

program plan has clear objectives that

are specific, measurable, and realistic,

and makes effective use of population

laboratory resources to advance the

population laboratory’s purpose.

3. Strategy and Technical Approach (45

points)

The technical and scientific merits of

the proposed projects, the potential to

achieve the stated objectives and the

extent to which the applicant’s plans are

consistent with the purpose of the

program.

a. Core activities (10 points)

—Description of the core activities of

the Urban Center.

b. Collaborations/collaborative projects

with State/local health departments and

academic institutions (35 points)

—Plan for including community-based

organizations, State and local health

departments, and academia in

planning, developing, and

implementing collaborative projects

(15 points)

—Plan for conducting collaborative

assessments to identify urban health

issues (5 points)

—Plan to identify, train, and involve

community residents in program

activities (5 points)

—Project descriptions of collaborative

projects (10 points)

4. Evaluation plan (5 points)

The extent to which the overall

population laboratory objectives will be

evaluated in regards to progress,

efficacy, and cost benefit to the urban

areas.

5. Management and staffing plan (15

points)

The extent to which the applicant

demonstrates the ability and capacity to

carry out the overall objectives and

specific project plans. Elements to

consider include:

(a) Demonstrated knowledge and

experience of the proposed project

director in planning and managing large

and complex interdisciplinary programs

involving public health and urban

issues (5 points);

(b) Demonstrated knowledge and

experience of the proposed staff in

carrying out the project objectives,

including the percentage of time each

person will devote to each project/

activity (5 points); and

(c) Institutional capacity,

demonstrated by the experience and

continuing capability of the State and

local health departments, academia, and

community-based organizations to

initiate and implement similar projects.

Applicant should describe previous

related efforts and the current capacity

of its collaborators/collaborating

organizations (5 points).

6. Institutionalization plan/

Collaboration (20 points)

The population laboratory’s plan for

collaborating and developing

relationships with local/State health

departments, academic/research

institutions, and community leaders.

Extent to which the applicant

demonstrates that proposed activities

are being conducted in conjunction

with, or through, organizations with

known and established ties in the

identified urban area. Evidence of

support and participation from

appropriate community-based

organizations in the form of memoranda

of understanding or other agreements of

collaboration.

7. Budget (not scored)

The extent to which the budget and

justification are consistent with the

program objectives and purpose.

Applicants are strongly urged to include

a plan for obtaining additional resources

that lead to institutionalization of the

population laboratory.

B. Review by senior Federal staff

Further review will be conducted by

Senior Federal staff.

Factors to be considered will be:

1. Results of the peer review.

2. Program needs and relevance to

national goals.

3. Budgetary considerations.

Executive Order 12372 Review

Applications are subject to the

Intergovernmental Review of Federal

Programs as governed by Executive

Order (E.O.) 12372. E.O. 12372 sets up

a system for State and local government

review of proposed Federal assistance

applications. Applicants should contact

their State Single Point of Contact

(SPOC) as early as possible to alert them

to the prospective applications and

receive any necessary instructions on

the State process. For proposed projects

serving more than one State, the

applicant is advised to contact the SPOC

of each affected State. A current list is

included in the application kit. If SPOC

have any State process

recommendations on applications

submitted to CDC, they should forward

them to Henry S. Cassell, III, Grants

Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E–13, Atlanta, Georgia 30305,

no later than 60 days after the deadline

date for new and competing awards.

The granting agency does not guarantee

to ‘‘accommodate or explain’’ State

process recommendations it receives

after that date.

Public Health System Reporting

Requirements

This program is subject to the Public

Health System Reporting Requirements.

Under these requirements, all

community-based nongovernmental

applicants must prepare and submit the
2974 Federal Register / Vol. 60, No. 8 / Thursday, January 12, 1995 / Notices

items identified below to the head of the

appropriate State and/or local health

agency(s) in the program area(s) that

may be impacted by the proposed

project no later than the receipt date of

the Federal application. The appropriate

State and/or local health agency is

determined by the applicant. The

following information must be

provided:

A. A copy of the face page of the

application (PHS 398, AA).

B. A summary of the project that should

be titled ‘‘Public Health System

Impact Statement’’ (PHSIS), not

exceed one page, and include the

following:

1. A description of the population to

be served;

2. A summary of the services to be

provided; and

3. A description of the coordination

plans with the appropriate State

and/or local health agencies.

If the State and/or local health official

should desire a copy of the entire

application, it may be obtained from the

SPOC or directly from the applicant.

Catalog of Federal Domestic Assistance

Number

The Catalog of Federal Domestic

Assistance number is 93.135.

Other Requirements

A. Paperwork Reduction Act

Projects that involve the collection of

information from 10 or more individuals

and funded by cooperative agreement

will be subject to review by the Office

of Management and Budget (OMB)

under the Paperwork Reduction Act.

B. Human Subjects

If the proposed project involves

research on human subjects, the

applicant must comply with the

Department of Health and Human

Services Regulations, 45 CFR Part 46,

regarding the protection of human

subjects. Assurance must be provided to

demonstrate that the project will be

subject to initial and continuing review

by an appropriate institutional review

committee. The applicant will be

responsible for providing assurance in

accordance with the appropriate

guidelines and form provided in the

application kit.

Application Submission and Deadlines

A. Preapplication Letter of Intent

Although it is not a prerequisite to

apply, potential applicants are

encouraged to submit a non-binding

letter of intent to apply to the Grants

Management Officer (whose address is

given in this section, Item B). It should

be postmarked on or before February 21,

1995. The letter should identify the

announcement number being responded

to, title and brief description of the

proposed population laboratory, and the

names and addresses of the principal

investigators. The letter of intent does

not influence review or funding

decisions, but it will enable CDC to plan

the review more efficiently.

B. Applications

Applicants should submit an original

and five copies of form PHS–398 (OMB

Number 0925–0001) to Henry S. Cassell,

III, Grants Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E–13, Atlanta, Georgia 30305,

on or before March 13, 1995.

C. Deadlines

Applications shall be considered as

meeting the deadline above if they are

either:

1. Received on or before the deadline

date; or

2. Sent on or before the deadline date

and received in time for submission to

the peer review committee. (Applicants

must request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

or the U.S. Postal Service. Private

metered postmarks shall not be

acceptable as proof of timely mailing.)

D. Late Applications

Applications which do not meet the

criteria in C.1 or C.2. above are

considered late applications. Late

applications will not be considered in

the current competition and will be

returned to the applicant.

Where to Obtain Additional

Information

A complete program description,

information on application procedures,

an application package, and business

management technical assistance may

be obtained from Georgia Jang, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E–13, Atlanta, Georgia 30305,

telephone (404) 842–6814.

Programmatic technical assistance may

be obtained from Mary Moreman,

Project Officer, Epidemiology Program

Office, Centers for Disease Control and

Prevention (CDC), 1600 Clifton Road,

NE., Mailstop C–08, Atlanta, Georgia

30333, telephone (404) 488–4390.

Please refer to Program

Announcement Number 515 when

requesting information and submitting

an application.

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report; Stock number 017–001–00474–

0) or Healthy People 2000 (Summary

Report; Stock number 017 001–00473–1)

through the Superintendent of

Documents, Government Printing

Office, Washington, DC 20402–9325,

telephone (202) 783–3238.

Dated: December 19, 1994.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

Attachment A

50 largest U.S. Cities with 200,000 or

more population ranked by population

per square mile, 1992 (reference: County

and City Data Book 1994)

New York, NY

San Francisco, CA

Jersey City, NJ

Chicago, IL

Philadelphia, PA

Boston, MA

Newark, NJ

Santa Ana, CA

Miami, FL

Washington, D.C.

Baltimore, MD

Long Beach, CA

Buffalo, NY

Los Angeles, CA

Detroit, MI

Oakland, CA

Minneapolis, MN

Pittsburgh, PA

Rochester, NY

Cleveland, OH

Milwaukee, WI

St. Louis, MO

Seattle, WA

Anaheim, CA

St. Paul, MN

Cincinnati, OH

Norfolk, VA

San Jose, CA

Honolulu, HI

Louisville, KY

Stockton, CA

Toledo, OH

Sacramento, CA

St. Petersburg, FL

Fresno, CA

Akron, OH

Portland, OR

Las Vegas, NE

San Diego, CA

Omaha, NE

Columbus, OH

Richmond, VA

Denver, CO

Houston, TX
Federal Register / Vol. 60, No. 8 / Thursday, January 12, 1995 / Notices 2975

Riverside, CA

Baton Rouge, LA

Albuquerque, NM

Atlanta, GA

Dallas, TX

Arlington, TX

Local Health Departments for the 50

Largest Urban Cities

New York City, Dept of Health, 125

Worth St., New York, NY 10013, (212)

788–5261

Los Angeles County Department of

Health Services, 313 North Figueroa,

Room 930, Los Angeles, CA 90012,

(213) 240–8156

Chicago Department of Health, DePaul

Center, 333 South State, 2nd Floor,

Chicago, IL 60602, (312) 747–9870

City of Houston Health and Human

Services, 8000 North Stadium Dr.,

Houston, TX 77054, (713) 794–9311

Philadelphia Department of Health,

1600 Arch St., Seventh Floor,

Philadelphia, PA 19103, (215) 686–

5043

San Diego County Department of Health

Services, Suite 211, 1700 Pacific

Highway, San Diego, CA 92101, (619)

236–7633

Detroit Health Department, Herman

Kiefer Health Complex, 1151 Taylor,

Detroit, MI 48202, (313) 876–4000

Dallas County Health Department, 1936

Amelia Court, Dallas, TX 75235–7795,

(214) 920–7910

Santa Clara County Health Department,

2220 Moorpark Ave., San Jose, CA

95128, (408) 299–2301

Baltimore City Health Department,

Eighth Floor, 303 East Fayette St.,

Baltimore, MD 21202, (410) 396–4387

San Francisco Department of Health,

101 Grove St., Suite 306, San

Francisco, CA 94102, (415) 554–2600

Franklin County Health Department,

410 South High St., Courthouse

Annex, Fifth Floor, Columbus, OH

43215, (614) 462–3160

City of Milwaukee Health Department,

841 North Broadway, Room 112,

Milwaukee, WI 53202, (414) 278–3521

District of Columbia Division of Public

Health, Suite 1200, 1660 L St., NW,

Washington, D.C. 20036, (202) 673–

7700

City of Boston Department of Health and

Hospitals, 818 Harrison Ave., Boston,

MA 02118, (617) 534–5365

Seattle/King County Health Department,

Suite 600, 110 Prefontaine Place,

South, Seattle, WA 98104, (206) 296–

4603

Cuyahoga County Health Department,

One Playhouse Square, 1375 Euclive

Ave., Cleveland, OH 44115, (216)

443–7500

Denver Department of Health, 605

Bannock, Denver, CO 80204, (303)

436–7200

Mulnomah County Department of

Health, Eighth Floor, 426 Southwest

Stark, Portland, OR 97204, (503) 248–

3674

Department of Health and Human

Services, City of Long Beach, 2525

Grand Ave., Long Beach, CA 90806,

(310) 570–4014

City of St. Louis, 634 North Grand,

Ninth Floor, St. Louis, MO 63103,

(314) 658–1140

Fulton County Health Department,

District 3, Unit 2, 99 Butler St., SE,

Atlanta, GA 30303, (404) 703–1205

District Health Department, Box 25846,

1111 Stanford Dr., N.E., Albuquerque,

NM 87125, (505) 841–4100

Alameda County Health Care Services

Agency, 409 Fifth St., Oakland, CA

94607, (510) 268–2727

Allegheny County Health Department,

3333 Forbes Ave., Pittsburgh, PA

15213–9913, (412) 578–8026

Sacramento County Health Department,

3701 Branch Center Rd., Sacramento,

CA 95827, (916) 366–2181

Hennepin County Community Health

Department, Third Floor, 525

Portland Ave., South, Minneapolis,

MN 55415, (612) 348–4382

Hawaii State Department of Health,

1250 Punchbowl St., PO Box 3378,

Honolulu, HI 96801, (808) 548–6505

Cincinnati Health Department, 3101

Burnet Ave., Cincinnati, OH 45229–

3098, (513) 357–7285

Dade County Health Department, 1350

Northwest 14th St., Miami, FL 33125,

(305) 324–2400

Fresno County Department of Health,

1221 Fulton Mall, PO Box 11867,

Fresno, CA 93775, (209) 445–3202

Douglas County Health Department,

1819 Farnam St., Room 401, Omaha,

NE 68183–0401, (402) 444–7472

Toledo Health Department, 635 North

Erie St., Health Center, Toledo, OH

43624, (419) 245–1711

Erie County Health Department, Rath

Office Building, 95 Franklin St.,

Buffalo, NY 14202, (716) 858–7690

Jersey City Division of Health, 586

Newark Ave., Jersey City, NJ 07306,

(201) 547–5168

Newark Department of Health, and

Welfare, 110 Williams St., Newark, NJ

07102, (201) 733–5310

Orange County Health Department, Box

355, Santa Ana, CA 92702, (714) 834–

3155

Monroe County Health Department, 111

Westfall Rd., Health and Social

Services Building, Rochester, NY

14692, (716) 274–6068

Dakota County Community Health

Services, Suite 345 West, 33 East

Wentworth, St. Paul, MN 55118, (612)

450–2608

Norfolk Department of Public Health,

Norfolk City Health District, 401

Colley Ave., Norfolk, VA 23507

Louisville/Jefferson County Health,

Department, PO Box 1704, Louisville,

KY 40202, (502) 625–6530

San Joaquin Local Health District, 1601

East Hazelton Ave., PO Box 20009,

Stockton, CA 95201, (209) 468–3411

Pinellas County Health Unit, 500

Seventh Ave., South, PO Box 13549,

St. Petersburg, GL 33701, (813) 824–

6924

Akron City Health Department, 177

South Broadway, Akron, OH 44308–

1799, (216) 375–2960

Clark County Health Department, PO

Box 4426, Las Vegas, NV 89106, (702)

383–1201

Henrico County Health Department,

Henrico Gov’t Center, Human

Services, 8600 Dixon Powers Dr., Box

27032, Richmond, VA 23273

Riverside County Health Department,

4065 County Circle Dr., Riverside, CA

92503, (909) 358–5058

Capitol Regional Health Department,

Region II, 1772 Wooddale Boulevard,

Baton Rouge, LA 70806, (504) 925–

7200

Texas Department of Health, Region #5,

2561 Matlock, Arlington, TX 76015,

(817) 459–6767.

[FR Doc. 95–790 Filed 1–11–95; 8:45 am]

BILLING CODE 4163–18–P

Food and Drug Administration

[Docket No. 94F–0415]

Ashland Chemical Co.; Filing of Food

Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Ashland Chemical Co., has filed a

petition proposing that the food additive

regulations be amended to provide for

the safe use of polypropylene glycol

with a molecular weight range of 1,200–

3,000 grams per mole (g/mol), as a

defoaming agent in processing beet

sugar and yeast.

FOR FURTHER INFORMATION CONTACT:

Aydin O ̈ rstan, Center for Food Safety

and Applied Nutrition (HFS–217), Food

and Drug Administration, 200 C St. SW.,

Washington, DC 20204–0002, 202–418–

3076.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a food additive

petition (FAP 5A4436) has been filed by